These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30382534)

  • 1. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
    Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
    Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
    Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
    Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
    Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
    Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
    Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
    Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
    Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
    BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of smoking on cognition and BDNF levels in a male Chinese population: relationship with BDNF Val66Met polymorphism.
    Xia H; Du X; Yin G; Zhang Y; Li X; Cai J; Huang X; Ning Y; Soares JC; Wu F; Zhang XY
    Sci Rep; 2019 Jan; 9(1):217. PubMed ID: 30659208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.
    Liu J; Yang W; Luo H; Ma Y; Zhao H; Dan X
    Aging Clin Exp Res; 2021 Jun; 33(6):1659-1666. PubMed ID: 32892314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
    J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism affects memory performance in older adults.
    Azeredo LA; De Nardi T; Levandowski ML; Tractenberg SG; Kommers-Molina J; Wieck A; Irigaray TQ; Silva IGD; Grassi-Oliveira R
    Braz J Psychiatry; 2017; 39(2):90-94. PubMed ID: 28099630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
    Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
    Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF Val66Met polymorphism and cognitive impairment in Parkinson's disease-a meta-analysis.
    Yin Y; Su X; Pan L; Li C
    Neurol Sci; 2019 Sep; 40(9):1901-1907. PubMed ID: 31104169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of Val66Met polymorphism of brain-derived neurotrophic factor gene with cognitive impairment and clinical symptoms in first episode schizophrenia].
    Zhang C; Gu X; Wang Q; Li M; Deng W; Guo W; Zhao L; Ma X; Li T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):592-596. PubMed ID: 28777866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
    Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Han Z; Qi L; Xu Q; Xu M; Cai L; Wong J; Hu X; Luo X; Wang J; Zhang Y; Li Y; Wang QM
    Neurorehabil Neural Repair; 2020 Mar; 34(3):247-259. PubMed ID: 32009534
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.
    Kheirollahi M; Kazemi E; Ashouri S
    Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
    Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
    Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus.
    Oroszi G; Lapteva L; Davis E; Yarboro CH; Weickert T; Roebuck-Spencer T; Bleiberg J; Rosenstein D; Pao M; Lipsky PE; Goldman D; Lipsky RH; Illei GG
    Ann Rheum Dis; 2006 Oct; 65(10):1330-5. PubMed ID: 16606648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
    Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
    Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.